Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant
- Resource Type
- Article
- Source
- In
Blood Advances 26 September 2023 7(18):5215-5224 - Subject
Clinical Trials and Observations Myeloid Neoplasia Transplantation - Language
- ISSN
- 2473-9529